91.5%
CLEC2AFred Hutch Cancer CenterAML
…remained disease-free in the bone marrow (figure 2).Conclusions CLEC2A is a novel, leukemia-specific immunotherapeutic target that is …
1articles mentioning drugs
11drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CLEC2A ×
CLEC2A
This drug is selected. Its supporting articles are shown below.